A
$ Value
$0
Shares
35,500
Price
$0
Filed
Jun 20
Insider
Name
Fawell Stephen
Title
—
CIK
0002033387
Roles
Director
Transaction Details
Transaction Date
2025-06-18
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
35,500
Footnotes
This option shall vest and become exercisable in full upon the earlier to occur of (i) June 18, 2026 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date.
Filing Info
Fawell Stephen's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-06-18 | CCCC | A | $0 |
Other Insiders at CCCC (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
REYNO LEONARD
Chief Medical Officer
|
— | — | 2026-02-14 |
|
Hirsch Andrew
President & CEO
|
— | — | 2026-02-15 |
| GROGAN DONNA ROY | — | — | 2026-04-01 |
|
Schick Kelly
Chief People Officer
|
— | — | 2026-02-14 |
| Anderson Kenneth Carl | — | — | 2026-04-01 |
|
Boyle Scott N
Chief Business Officer
|
— | — | 2026-02-14 |
|
Adams Kendra
Chief Financial Officer
|
— | — | 2026-02-14 |
|
Mossler Mark
Chief Accounting Officer
|
— | — | 2026-02-14 |
|
Mahaney Paige
Chief Scientific Officer
|
— | — | 2026-02-14 |